Immunogen, Inc.
Immunogen, Inc.'s phone number is 781-895-0600
.
ImmunoGen, Inc. engages in the research and development of antibody-based anticancer therapeutics in the United States. The company develops therapeutics for the treatment of cancer using its Targeted Antibody Payload (TAP) technology, which uses antibodies to deliver a potent cytotoxic agent. Its products include Trastuzumab-DM1, a Phase II clinical trial product for the treatment of metastatic breast cancer; IMGN901, a Phase I clinical trial product to treat hematological malignancies, including multiple myeloma, small-cell lung cancer, Merkel cell carcinoma, and other...
read more
ImmunoGen, Inc. engages in the research and development of antibody-based anticancer therapeutics in the United States. The company develops therapeutics for the treatment of cancer using its Targeted Antibody Payload (TAP) technology, which uses antibodies to deliver a potent cytotoxic agent. Its products include Trastuzumab-DM1, a Phase II clinical trial product for the treatment of metastatic breast cancer; IMGN901, a Phase I clinical trial product to treat hematological malignancies, including multiple myeloma, small-cell lung cancer, Merkel cell carcinoma, and other cancers of neuroendocrine origin; SAR3419, a Phase I clinical trial product for the treatment of B-cell hematological malignancies, including non-Hodgkin's lymphoma; and IMGN388 and BIIB015, which are in Phase I clinical trials for the treatment of solid tumors. The company's products also comprise BT-062, a Phase I clinical trial product targeting multiple myeloma; SAR566658, a preclinical trail product for the treatment of breast, ovarian, and other solid tumors; SAR650984, a preclinical trail product to treat hematological malignancies; and TAP and other compounds. It has licensing or collaboration agreements with sanofi-aventis; Genentech, Inc.; Biotest AG; Bayer HealthCare AG; Biogen Idec; Amgen, Inc.; Centocor, Inc.; Cytovance Biologics LLC; Laureate Pharma, Inc.; BioInvent International AB; Diosynth RTP, Inc.; and Societa Italiana Corticosteroidi S.r.l. ImmunoGen was founded in 1981 and is headquartered in Waltham, Massachusetts.
show less
Website | immunogen.com | |
Industry | Biotechnology | |
Location | Waltham, Massachusetts, United States | |
Employees | 239 | |
Founded | 1981 |
HQ | 830 Winter Street | |
Phone | 781-895-0600 | |
Funding | 55,000,000 USD | |
Competitors | Roche, Agilent Technologies, Amgen, Genentech, Eurofins, Gilead Sciences, |
Website | immunogen.com | |
Industry | Biotechnology | |
Location | Waltham, Massachusetts, United States | |
Employees | 239 | |
Founded | 1981 | |
linkedin.com/company/immunogen-inc. | ||
HQ | 830 Winter Street | |
Phone | 781-895-0600 | |
Funding | 55,000,000 USD |
Email Patterns for Immunogen, Inc.
Top Competitors for Immunogen, Inc.
Immunogen, Inc. Questions
Where are Immunogen, Inc.'s headquarters?
Immunogen, Inc.'s headquarters are in 830 Winter Street
What is Immunogen, Inc.'s phone number?
Immunogen, Inc.'s phone number is 781-895-0600
What is Immunogen, Inc.'s official website?
Immunogen, Inc.'s website is immunogen.com
How many employees are working in Immunogen, Inc. right now?
Immunogen, Inc. has
239 employees.
View the Email and Phone Numbers for all 239 working at Immunogen, Inc..
What is Immunogen, Inc.'s industry?
Immunogen, Inc.'s industry is
Biotechnology
Who are Immunogen, Inc.'s top competitors?
Immunogen, Inc.'s top competitors are
Roche
,
Agilent Technologies
,
Amgen
,
Genentech
,
Eurofins
,
Gilead Sciences
What are Immunogen, Inc.'s categories?
Immunogen, Inc.'s categories are Biotechnology, Health Care, Medical, Therapeutics
What is Immunogen, Inc.'s location?
Immunogen, Inc.'s location is
Waltham, Massachusetts, United States
When was Immunogen, Inc.'s founded?
Immunogen, Inc.'s founding year is 1981
What is Immunogen, Inc.'s funding?
Immunogen, Inc.'s funding is 55,000,000 USD
What is Immunogen, Inc.'s current status?
Immunogen, Inc.'s current status is ipo
Top Immunogen, Inc. Employees
Associate Director, Quality Systems
mosgofian928@yahoo.com
+1413-461-5021
Vice President Finance
renee.lentini@immunogen.com
+1781-895-0600
Former Senior Auditor
bruce.bates@immunogen.com
+1781-762-1352
Senior Vice President Of Regulatory Affairs And Quality
twingrove@comcast.net
+1781-895-0600
Senior Validation Engineer
eric.tofteroo@immunogen.com
+1617-995-2500
Research Associate Iii
sara.eglitis@immunogen.com
+1781-895-0600
Scientist
ruiwulin@gmail.com
+1781-895-0600